Want to join the conversation?
Pharmaceuticals and consumer packaged goods manufacturer $JNJ's subsidiary Janssen Biotech announced that the US FDA has approved DARZALEX (daratumumab) injection for IV infusion for the treatment of multiple myeloma, an incurable blood cancer that happens due to abnormal plasma cells accumulating in the bone marrow.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.